Ventricular Tachycardia Ablation vs. Enhanced Drug Therapy In Structural Heart Disease - The VANISH Trial

Grant

Date/time Interval

  • June 30, 2011 - June 29, 2012

    • Awarded By

    Total Award Amount

  • 3850.00

    • Direct Costs

  • 3850.00

    • Sponsor Award Id

    • Contributor

  • George Kay   Principal Investigator  
  • Tom McElderry   Investigator